Dheeraj Kumar

Dr. Dheeraj Kumar


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2025 in Journal of the National Medical Association
Verified
Journal Article
Closed access
TATanisha Anand
Tanisha Anand
PMPriya Mishra
Priya Mishra
MSMahima Saxena
Mahima Saxena
UNUmra Naeem
Umra Naeem
AJAnushka Jauhari
Anushka Jauhari
DKDheeraj Kumar
Dheeraj Kumar

21 January 2026 in KIDNEYS
Verified
Journal Article
Open access
AKAlka Katiyar
Alka Katiyar
MRMunish Rastogi
Munish Rastogi
PTPradeep Kumar Tiwari
Pradeep Kumar Tiwari
DKDheeraj Kumar
Dheeraj Kumar
Renal diagnostics are central to modern nephrology, guiding the evaluation, staging, and management of chronic kidney disease (CKD) and acute kidney injury (AKI). However, most laboratory errors occur in the pre-analytical phase, including patient preparation, specimen collection, labeling, handling, transport, and storage. Such upstream failures can significantly compromise the accuracy of kidney biomarkers such as serum creatinine, estimated glomerular filtration rate (eGFR), albuminuria, and electrolytes. This review examines the classification, burden, and clinical impact of pre-analytical errors in renal diagnostic testing, emphasizing their implications for kidney disease evaluation, patient safety, and evidence-based clinical decision-making. A narrative synthesis of recent nephrology and laboratory medicine literature was conducted, focusing on major categories of pre-analytical failure, including identification errors, specimen collection problems, sample interferences, transport instability, and medication- or physiology-related confounders. Specialized nephrology populations and emerging quality improvement strategies were also reviewed. Pre-analytical errors may lead to CKD misclassification, inaccurate eGFR estimation, unreliable urine albumin-to-creatinine ratio testing, and delayed AKI recognition. High-risk groups such as pediatric patients, lupus nephritis populations, oncology-associated kidney injury cases, and perioperative surgical patients are particularly vulnerable. Clinical consequences include inappropriate drug dosing, avoidable dialysis initiation, unnecessary hospital admissions, and increased healthcare resource utilization. Standardization initiatives, quality indicators, harmonization frameworks, and innovations such as artificial intelligence, delta checks, and smart sample tracking offer promising approaches to reduce preventable diagnostic variability. Strengthening pre-analytical integrity is essential for accurate renal biomarker interpretation, guideline-concordant CKD management, and improved patient outcomes.

1 October 2026 in Indian Journal of Radiology and Imaging
Verified
Journal Article
Open access
MZMohd. Umar Zakee
Mohd. Umar Zakee
RRRajul Rastogi
Rajul Rastogi
DKDheeraj Kumar
Dheeraj Kumar
Disorders of sex development (DSD) are rare congenital conditions characterized by discordance between chromosomal, gonadal, and phenotypic sex. Adult presentation is uncommon and frequently associated with delayed diagnosis. We report a rare case of a 42-year-old phenotypic male presenting with infertility, ambiguous genitalia, and bilateral non-palpable testes. Magnetic resonance imaging (MRI) performed for evaluation of suspected undescended testes revealed a rudimentary uterus, bilateral ovarian tissue, a proximal vaginal canal, hypoplastic prostate, and bilateral adrenal hyperplasia. A fat-containing left adrenal lesion consistent with adrenal myelolipoma was also identified. Hormonal evaluation demonstrated elevated serum 17-hydroxyprogesterone levels with reduced testosterone levels. Karyotype analysis revealed a 46,XX chromosomal pattern. MRI provided comprehensive anatomical characterization of internal reproductive and adrenal abnormalities, facilitating the diagnosis of congenital adrenal hyperplasia-associated disorder of sex development. This case highlights the indispensable role of MRI in evaluating adult DSD and emphasizes the importance of multidisciplinary clinical, endocrine, genetic, and radiological correlation for accurate diagnosis and management.

15 October 2026
Verified
Book Chapter
Open access
PDF file
DKDheeraj Kumar
Dheeraj Kumar
KSKartika Sharma
Kartika Sharma
ASAnkit Shukla
Ankit Shukla
Medical imaging produces more data than almost any other branch of clinical medicine, and the number of trained eyes available to read it has not kept pace. Artificial intelligence (AI), and deep learning in particular, has moved from research laboratories into reading rooms over the past decade and now assists with tasks that range from sharpening noisy scans to flagging a possible cancer on a screening mammogram. This chapter introduces the subject for students and early-career professionals in radiology and the allied health sciences. It traces how the field grew from rule-based computer-aided detection to modern neural networks, explains the core ideas in plain language, and shows where AI enters the imaging workflow. Landmark clinical studies are summarised alongside the measures used to judge performance. The chapter also examines the practical limits of current tools, including bias, poor generalisation and thin clinical evidence, and outlines the ethical and regulatory questions that accompany their use.

29 July 2025 in Acta medica Lituanica
Verified
Journal Article
Open access
SYSandeep Yadav
Sandeep Yadav
VRVrinda
Vrinda
PKPankaj Kumar
Pankaj Kumar
SYSantosh Kumar Yadav
Santosh Kumar Yadav
DKDheeraj Kumar
Dheeraj Kumar
Neurocysticercosis (NCC), a parasitic infection of the central nervous system caused by Taenia solium larvae, is a leading cause of acquired epilepsy in endemic regions. This case describes a 40-year-old male who presented with chronic headache, dizziness, and a recent seizure episode. He had no prior history of systemic illness, tuberculosis, or neurological disorders. Magnetic Resonance Imaging (MRI) of the brain revealed multiple ring-enhancing lesions with an eccentric scolex in the cerebral and cerebellar hemispheres, accompanied by surrounding edema, confirming the diagnosis of neurocysticercosis. Additional lesions in extraocular, facial, and tongue muscles were consistent with myocysticercosis, an uncommon but clinically significant manifestation that may mimic inflammatory or neoplastic processes.Spinal imaging demonstrated degenerative changes, including diffuse cervical disc bulges at multiple levels (C3–C7) and lumbar disc pathology at L4–L5, causing anterior thecal sac indentation but without cord compression or myelomalacia. While the spinal findings were incidental, they were clinically relevant as contributors to chronic pain and potential neurological deficits.The coexistence of disseminated neurocysticercosis with muscular involvement and early degenerative spinal disease highlights the importance of comprehensive evaluation in patients presenting with seizures and persistent headache. Treatment included albendazole-based antiparasitic therapy, corticosteroids to reduce perilesional edema, antiepileptic medications, and conservative management for disc disease.This case underscores the role of MRI in identifying pathognomonic features of cysticercosis, emphasizes the need for systemic evaluation, and demonstrates the significance of recognizing coexisting pathologies for tailored multidisciplinary management.

15 October 2026
Verified
Book Chapter
Open access
PDF file
ASAtul Kumar Singh
Atul Kumar Singh
DKDheeraj Kumar
Dheeraj Kumar
SKSaman Khan
Saman Khan
An imaging algorithm that scores well on its own test set may still fail in the clinic. It may have learned a shortcut in the data and not the disease. It may work for some groups of patients and not for others. It may be upset by a new scanner or a change in the population, and its probabilities may mean something different where disease is rarer. This chapter deals with the four properties that decide whether an algorithm can be trusted: whether its decisions can be explained, whether it is fair, whether it is robust, and whether it has been properly validated. It describes what explanation methods show and what they do not, the sources of bias along the path from patient to prediction, the effects of dataset shift and deliberate perturbation, calibration, the ladder of evidence from internal testing to clinical trials, and the reporting standards that now apply. Simulations computed for the chapter illustrate a shortcut, an under-represented group, a deliberate perturbation, miscalibration and the gap between internal and external performance. The final sections cover monitoring after deployment and the questions to ask of any product.